Innovation in the treatment of persistent pain in adults with Neurofibromatosis Type 1 (NF1): Implementation of the iCanCope mobile application
Sign Up to like & getrecommendations! Published in 2022 at "Contemporary Clinical Trials Communications"
DOI: 10.1016/j.conctc.2021.100883
Abstract: Neurofibromatosis Type 1 (NF1) is a genetic disorder presenting with chronic pain symptoms that has limited treatment options for addressing the pain. The utilization of a mobile application allows for greater reach and scalability when… read more here.
Keywords: neurofibromatosis type; icancope mobile; pain; treatment ... See more keywords